HK inno.N
医薬品製剤、ジェネリック医薬品、ヘルスケア製品。
HK inno.N は、ソウルの事業所で医薬品製剤、ジェネリック医薬品、ヘルスケア製品を製造しています。同社は、上場主要市場全体の薬局チャネル、病院バイヤー、ヘルスケア流通業者、または輸出顧客に製品を供給しています。
- Type
- Manufacturer
- Location
- Seoul, South Korea
- Founded
- 1984
- Website
- hkinno-n.com
- Categories
- 医療およびヘルスケア用品, サプリメントとウェルネス
- Markets
- 韓国, 中国, アメリカ合衆国, 日本
Claimed certifications
- Good Manufacturing Practice
- ISO 9001, Quality Management IAF CertSearch
Import rules for these goods
- Food supplements sold in the EU follow Directive 2002/46/EC: most member states require a notification to the national authority before the first sale. European Commission (supplements)
- Medical devices sold in the EU must carry CE marking under the Medical Device Regulation (EU) 2017/745, with a conformity assessment matched to the device risk class. European Commission (MDR)
- For the US market, the maker must have an FDA device establishment registration and product listing; most instruments also need 510(k) premarket clearance. US FDA (devices)